logo
The key lesson of family planning programmes for HIV/AIDS control
Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells
Early induction of leukemia inhibitor factor (LIF) in acute HIV-1 infection
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy
Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients
Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya
Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease
Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy
Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda
Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas
Economic impact of antiretroviral therapy prescription decisions in the context of rapid scaling-up of access to treatment: lessons from Mexico
Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART
To serve and protect? Toward a better relationship between drug control policy and public health
Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART
Heterosexual anal intercourse increases risk of HIV infection among young South African men
Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection
High rate of proV47A selection in HIV-2 patients failing lopinavir-based HAART
Once-daily directly observed therapy lopinavir/ritonavir plus indinavir as a protease inhibitor-only salvage therapy in heavily pretreated HIV-1-infected patients: a pilot study
Efavirenz 600 mg/day versus efavirenz 800 mg/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results
Problems in medical injection study
Reply to ‘Problems in medical injection study’
A case of transient hyperphosphatasemia of infancy and early childhood in an HIV-positive adult possibly related to atazanavir
Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature review
Evolution of resistance during first-line treatment with boosted fosamprenavir is associated with baseline mutations
Adherence without access to antiretroviral therapy in sub-Saharan Africa?
Response to Bangsberg et al., regarding our article ‘No room for complacency about adherence to antiretroviral therapy in Africa’